resiquimod

Resiquimod (R848) is an agonist of Toll-like receptors 7 and 8 (TLR7/TLR8) that induces the upregulation of cytokines including TNF-α, IL-6, and IFN-α. It possesses immunomodulatory, antitumor, and antiviral activities, and can be used to induce models of myocarditis and systemic lupus erythematosus (SLE).

Resiquimod-D5 is the deuterated form of Resiquimod (T6964). It acts as an agonist for TLR7 and TLR8, which can induce the upregulation of cytokines such as TNF-α, IL-6, and IFN-α.